Biểu đồ giá cổ phiếu ADMA
ADMA Dự đoán giá cổ phiếu
ADMA Biologics Inc
$9.75
-1.51%
$-0.15
Khi đóng cửa: Aug 10, 16:00:00 GMT-4
$9.75
0%
$0
Phiên trước giờ: Aug 11, 04:47:55 GMT-4
Quay lại
ADMA Biologics Inc (ADMA) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$9.9
Giá mở cửa
$9.8
Phạm vi ngày
$9.7 - $10.05
Phạm vi 52 tuần
$7.21 - $20.45
Khối lượng
1.8M
Khối lượng trung bình
5.9M
Tỷ suất cổ tức
--
EPS (TTM)
0.68
Vốn hóa thị trường
$2.2B
ADMA là gì?
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 647 full-time employees. The company went IPO on 2013-10-17. The firm manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
